Table 4.
Zeng 2017 [16] | Pirrera 2017 [17] | Forsmo 2017 [18] | Braga 2017 [19] | Braga 2016 [20] | Gonzalez-Ayora 2016 [21] | Pedziwiatr 2015 [22] | Kisialeuski 2015 [23] | Jia 2014 [24] | Keller 2013 [25] | Feroci 2013 [26] | Baek 2013 [27] | Wang 2012 [28] | Pawa 2012 [29] | Walter 2011 [30] | Kahokehr 2011 [31] | Rumstadt 2009 [32] | Hendry 2009 [33] | Scharfenberg 2007 [34] | Senagore 2003 [35] | Bardram 2000 [36] | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age (years) | ≥75 | 66–75 | > 75 | 66–79 | ≥80 | 71–75 | 76–80 | > 80 | ≥70 | ≥70 | ≥80 | > 65 | ≥70 | ≥70 | ≥75 | ≥70 | ≥65 | ≥80 | ≥80 | > 75 | 70–79 | ≥80 | ≥80 | ≥70 | ≥70 | ≥70 |
n of patients | 94 | 175 | 203 | 56 | 19 | 105 | 117 | 93 | 329 | 188 | 34 | 49 | 117 | 153 | 204 | 77 | 40 | 130 | 68 | 22 | 535 | 207 | 194 | 74 | 173 | 39 |
MORBIDITY1 (in %) | ||||||||||||||||||||||||||
- inH | 21.1 | 21.2 | 37.8 | 23.5 | 36.7 | 17.0 | 26.0 | 5.0 | 31.2 | |||||||||||||||||
- 30d | 24.5 | 41.2 | 52.6 | 21.0 | 18.8 | 30.1 | 29.8 | 37.3 | 23.0 | 38.2 | 33.0 | 21.6 | 20.5 | |||||||||||||
MORTALITY (in %) | ||||||||||||||||||||||||||
- inH | 0 | 0 | 0 | 1.6 | 0 | 0 | 0 | 0 | 0 | 1.2 | ||||||||||||||||
- 30d | 2.1 | 3.6 | 5.3 | 0 | 0 | 0 | 0.3 | 0 | 6.4 | 16.2 | 4 | 0 | 1.1 | 1.0 | 3.1 | 1.4 | 5.1 | |||||||||
LOS (in days) | ||||||||||||||||||||||||||
- Post-operative (mean, ±SD) |
4.7 ± 4.5 |
4.7 ±5.1 |
6.2 ± 3.1 | 6.7 ± 3.5 | 7.3 ± 3.6 |
5.4 ±5 |
5.5 ± 4 |
|||||||||||||||||||
- Post-operative (median, range) |
6 (4–21) |
5 (2–21) |
6.5 (3–50) |
6 (IQR 5–81 and 4–72) |
5 (IQR 3–7) |
7 (3–43) |
8 (4–27) |
5.5 (IQR 5–6) | 7 (IQR 6–10) |
8 (2–83) |
11 (1–53) |
5 (3–56) |
2.5 (2–90) | |||||||||||||
- total (mean, ±SD) |
9.0 ±1.75 |
5.0 ±4.91 |
||||||||||||||||||||||||
- total (median, range) |
12 (7–31) |
8 (IQR 5–14) | 6 (IQR 3–8) | |||||||||||||||||||||||
READMISSION (in %) - 30d |
4.6 | 4.9 | 25.0 | 21.1 | 5.7 | 1.7 | 1.1 | 2.4 | 6.4 | 2.9 | 6.1 | 4.6 | 1.5 | 11.7 | 6.2 | 4 | 4.7 | 2.4 | 12.2 | 6.4 | 5.1 | |||||
REOPERATION (in %) | 5.3 | 1.2 | 3.4 | 14.3 | 10.5 | 5 | 5 | 4 | 5.2 | 8.5 | 0 | 4.1 | 1.3 | 8.5 | 0.6 | 7.7 |
LEGEND: 1postoperative complications (Clavien-Dindo severity grades I to IV); n: number; d: days; inH: in-hospital; 1result for ASA 1,2 patients; 2result for ASA 3,4 patients; ASA: American Society of Anaesthesiologists physical status classification; SD: standard deviation; IQR: inter quartile range